Drug-induced lupus (DIL) is due to an autoimmune reaction to a drug with an estimated incidence of 15,000 to 30,000 cases every year in the US. Hydralazine is a well-known offender. Antinuclear antibody (ANA) is present in most cases, though four cases of ANA-negative DIL have been reported. In this report, we present another case of ANA-negative DIL secondary to hydralazine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650239 | PMC |
| http://dx.doi.org/10.1080/08998280.2019.1613331 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hydralazine-induced pericardial effusion.
Proc (Bayl Univ Med Cent)
July 2019
Division of Nephrology, Baylor University Medical CenterDallasTexas.
Drug-induced lupus (DIL) is due to an autoimmune reaction to a drug with an estimated incidence of 15,000 to 30,000 cases every year in the US. Hydralazine is a well-known offender. Antinuclear antibody (ANA) is present in most cases, though four cases of ANA-negative DIL have been reported.
View Article and Find Full Text PDFAntinuclear antibody-negative, drug-induced lupus caused by lisinopril.
South Med J
November 2001
Department of Internal Medicine, University of South Florida College of Medicine, Tampa 33612, USA.
The clinical symptoms of drug-induced lupus (DIL) are similar to those of idiopathic systemic lupus erythematosus. The literature indicates that in patients with DIL, sera generally contain antinuclear antibodies (ANAs); however, ANA-negative DIL has been reported. The list of medications implicated as etiologic agents in DIL continues to grow.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!